PETRACCA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 700
NA - Nord America 669
AS - Asia 85
AF - Africa 26
OC - Oceania 1
Totale 1.481
Nazione #
US - Stati Uniti d'America 654
IT - Italia 385
DE - Germania 155
NL - Olanda 54
CN - Cina 48
UA - Ucraina 37
CI - Costa d'Avorio 26
IN - India 22
FI - Finlandia 18
IE - Irlanda 16
CA - Canada 15
GB - Regno Unito 13
VN - Vietnam 8
CH - Svizzera 4
IR - Iran 4
SE - Svezia 4
FR - Francia 3
BG - Bulgaria 2
MK - Macedonia 2
PL - Polonia 2
RS - Serbia 2
TW - Taiwan 2
AU - Australia 1
BE - Belgio 1
PT - Portogallo 1
RO - Romania 1
SG - Singapore 1
Totale 1.481
Città #
Chandler 121
Ashburn 95
Naples 67
Amsterdam 54
Napoli 37
Krefeld 33
Millbury 33
Lawrence 25
Beijing 22
Des Moines 20
Boston 18
Milan 16
Rottweil 15
Princeton 12
Nanjing 10
Pune 10
Rome 10
Wilmington 10
Dong Ket 8
Norwalk 8
Seattle 8
Washington 8
Ottawa 7
Bari 6
Dublin 6
Marano 6
Udine 6
Vicenza 6
Caposele 5
Casoria 5
Helsinki 4
Kronberg 4
New York 4
Ravenna 4
San Quirino 4
Suffern 4
Toronto 4
Trapani 4
Turin 4
Ardabil 3
Augusta 3
Bologna 3
Fairfield 3
Formia 3
Lappeenranta 3
Shenzhen 3
Trento 3
Woodbridge 3
Ann Arbor 2
Arcore 2
Aversa 2
Calvizzano 2
Caserta 2
Council Bluffs 2
Dallas 2
Grottaferrata 2
Hangzhou 2
Jacksonville 2
Jiaxing 2
Las Vegas 2
London 2
Montreal 2
Nanchang 2
Orange 2
Rapallo 2
Redhill 2
San Diego 2
San Gennaro Vesuviano 2
Serre 2
Shenyang 2
Sofia 2
Tianjin 2
Vietri Sul Mare 2
Acerra 1
Andover 1
Aprilia 1
Barrie 1
Bellona 1
Boardman 1
Borgaro Torinese 1
Brusciano 1
Brussels 1
Cantalupo In Sabina 1
Capaccio 1
Capodrise 1
Capri 1
Edinburgh 1
Faenza 1
Falkenstein 1
Falls Church 1
Florence 1
Geislingen an der Steige 1
Guangzhou 1
Harrisburg 1
Hebei 1
Houston 1
Indiana 1
Kunming 1
Lake Forest 1
Leawood 1
Totale 827
Nome #
Neurologia per le professioni sanitarie 176
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature 155
GBA-Related Parkinson’s Disease:Dissection of Genotype–Phenotype Correlates in a LargeItalian Cohort 65
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 62
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis 56
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis 38
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach 38
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice 35
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 33
The Italian Dystonia Registry: rationale, design and preliminary findings 33
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis 32
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 32
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 30
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis 30
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak 29
Cerebellar lobule atrophy and disability in progressive MS 28
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions 27
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 27
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 27
Efficacy of levetiracetam in hemifacial spasm: a case report. 24
Idiopathic late-onset cerebellar ataxia with cerebellar atrophy in a patient diagnosed with Chiari I malformation: a case report. 24
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 24
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. 23
A retrospective exploratory analysis on cardiovascular risk and cognitive dysfunction in multiple sclerosis 23
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 22
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 22
Tolosa-Hunt syndrome in a patient with autoimmune hemolytic anemia. 22
Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. 22
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience 22
Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy) 21
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 20
Glossopharyngeal neuralgia as onset of multiple sclerosis. 20
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 20
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 20
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 19
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 19
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 19
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study 18
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis 17
Adult onset Rasmussen’s Encephalitis: a case report. 17
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 15
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study 14
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis 14
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study 14
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report. 14
Signs and symptoms of COVID-19 in patients with multiple sclerosis 13
Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020 13
Walk your talk: Real-world adherence to guidelines on the use of MRI in multiple sclerosis 13
Quantitative MRI in Multiple Sclerosis: From Theory to Application 12
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy 10
Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis 10
Retinal and choriocapillary vascular changes in early stages of multiple sclerosis: A prospective study 9
Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis 8
Disability outcomes in early-stage African American and White people with multiple sclerosis 7
Prevalence of autoimmine thyroiditis In an Italian multiple sclerosis cohort 7
Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging 4
The development of subcortical gray matter atrophy in multiple sclerosis: One size does not fit all 4
Assessing brain involvement in Fabry disease with deep learning and the brain‐age paradigm 3
An MRI evaluation of grey matter damage in African Americans with MS 2
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 1
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis 1
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis 1
Totale 1.580
Categoria #
all - tutte 6.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 2 4 5 0
2019/2020108 20 7 3 2 6 2 5 9 2 22 22 8
2020/2021171 18 10 13 26 12 14 7 6 16 18 16 15
2021/2022284 14 5 10 9 6 21 9 11 37 17 55 90
2022/2023586 43 59 13 9 40 66 151 28 62 61 37 17
2023/2024349 16 63 45 37 29 82 13 45 19 0 0 0
Totale 1.580